Phenylephrine

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

Topical sympathomimetic, vasoconstrictive.

IndicationThis section has been translated automatically.

Allergic rhinitis. S.a. β sympathomimetics, inhaled.

Limited indicationThis section has been translated automatically.

Pregnancy, nursing.

Dosage and method of useThis section has been translated automatically.

Several times a day, 1 trp. in each nostril. eye drops: Several times a day, 1 trp. in the eyes. limit the application time to 14 days!

Standard concentrationThis section has been translated automatically.

Eye drops: 0.125%.

Undesirable effectsThis section has been translated automatically.

Hyperhidrosis, tachyphylaxis.

InteractionsThis section has been translated automatically.

The simultaneous intake of tricyclic antidepressants increases the risk of triggering a glaucoma attack.

ContraindicationThis section has been translated automatically.

Narrow-angle glaucoma, MAO-A inhibitor.

PreparationsThis section has been translated automatically.

Visadron, Neo-Mydrial, Neosynephrine POS, Otriven Baby Phenylephrine

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer